1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ADAPTIVE BIOTECHNOLOGIES CORP
Adaptive Biotechnologies Corp XNAS: ADPT

Adaptive Biotechnologies Corp Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

Read More
19.72 -0.60 (-2.95%)
New 52W High in past week
1.9M
XNAS Volume

XNAS 26 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Insider Trade
Sharon Benzeno, CCO & 10% owner of Adaptive Biotechnologies, sells 606K shares worth $10.1 million See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
8.7 / 100
Momentum Score
Technically Bullish
78.4 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
20
1Yr Price target downside is -1%
7 analysts

21

S

9

W

3

O

2

T

SWOT Analysis

Adaptive Biotechnologies Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..